Farther Finance Advisors’s iRadimed IRMD Stock Holding History

Farther Finance Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.1K	Sell	275 -185	-40%	-$16.9K	﹤0.01%	3781
2026 Q1	$44.4K	Buy	460 +15	+3%	+$1.5K	﹤0.01%	3075
2025 Q4	$43.3K	Buy	445 +397	+827%	+$34.1K	﹤0.01%	2914
2025 Q3	$3.42K	Buy	48 +24	+100%	+$1.6K	﹤0.01%	3922
2025 Q2	$1.44K	Hold	24	–	–	﹤0.01%	3805
2025 Q1	$1.28K	Hold	24	–	–	﹤0.01%	3541
2024 Q4	$1.32K	Hold	24	–	–	﹤0.01%	3158
2024 Q3	$1.21K	Hold	24	–	–	﹤0.01%	3180
2024 Q2	$1.04K	Hold	24	–	–	﹤0.01%	3066
2024 Q1	$1.03K	Hold	24	–	–	﹤0.01%	2761
2023 Q4	$1.14K	Hold	24	–	–	﹤0.01%	2665
2023 Q3	$1.06K	Hold	24	–	–	﹤0.01%	2066
2023 Q2	$1.15K	Hold	24	–	–	﹤0.01%	1929
2023 Q1	$944	Hold	24	–	–	﹤0.01%	1860
2022 Q4	$679	Buy	+24	New	+$687	﹤0.01%	1752

Other funds holding IRMD

Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

KPP

Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

1IA

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

Farther Finance Advisors's IRMD Position: Q2 2026 in Review

Farther Finance Advisors reduced its iRadimed (IRMD) stake by 40% in Q2 2026, selling an estimated $16.9K and leaving 275 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3781.

Farther Finance Advisors first reported a position in IRMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $44.4K in Q1 2026. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Farther Finance Advisors held 275 shares of iRadimed worth $26.1K as of Q2 2026.
Farther Finance Advisors sold 185 iRadimed shares in Q2 2026, an estimated $16.9K.
iRadimed made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3781 holding.
Farther Finance Advisors first reported a position in iRadimed in Q4 2022 and has held it in 15 quarters since.
Farther Finance Advisors's iRadimed position peaked at $44.4K in Q1 2026.
18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.